93 related articles for article (PubMed ID: 20967466)
1. Effects of human full-length amelogenin on the proliferation of human mesenchymal stem cells derived from bone marrow.
Huang YC; Tanimoto K; Tanne Y; Kamiya T; Kunimatsu R; Michida M; Yoshioka M; Yoshimi Y; Kato Y; Tanne K
Cell Tissue Res; 2010 Nov; 342(2):205-12. PubMed ID: 20967466
[TBL] [Abstract][Full Text] [Related]
2. Effects of Human Full-length Amelogenin and C-terminal Amelogenin Peptide on the Proliferation of Human Mesenchymal Stem Cells Derived from Adipose Tissue.
Ando K; Kunimatsu R; Awada T; Yoshimi Y; Tsuka Y; Sumi K; Horie K; Abe T; Nakajima K; Tanimoto K
Curr Pharm Des; 2018; 24(25):2993-3001. PubMed ID: 30112985
[TBL] [Abstract][Full Text] [Related]
3. The C-terminus of the amelogenin peptide influences the proliferation of human bone marrow mesenchymal stem cells.
Kunimatsu R; Awada T; Yoshimi Y; Ando K; Hirose N; Tanne Y; Sumi K; Tanimoto K
J Periodontol; 2018 Apr; 89(4):496-505. PubMed ID: 29683502
[TBL] [Abstract][Full Text] [Related]
4. Amelogenin enhances the osteogenic differentiation of mesenchymal stem cells derived from bone marrow.
Tanimoto K; Huang YC; Tanne Y; Kunimatsu R; Michida M; Yoshioka M; Ozaki N; Sasamoto T; Yoshimi Y; Kato Y; Tanne K
Cells Tissues Organs; 2012; 196(5):411-9. PubMed ID: 22653431
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women.
Rodríguez JP; Ríos S; Fernández M; Santibañez JF
J Cell Biochem; 2004 Jul; 92(4):745-54. PubMed ID: 15211572
[TBL] [Abstract][Full Text] [Related]
6. Amelogenin enhances the proliferation of cementoblast lineage cells.
Kunimatsu R; Tanimoto K; Tanne Y; Kamiya T; Ohkuma S; Huang YC; Yoshimi Y; Miyauchi M; Takata T; Tanne K
J Periodontol; 2011 Nov; 82(11):1632-8. PubMed ID: 21486179
[TBL] [Abstract][Full Text] [Related]
7. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
[TBL] [Abstract][Full Text] [Related]
8. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
Longobardi L; O'Rear L; Aakula S; Johnstone B; Shimer K; Chytil A; Horton WA; Moses HL; Spagnoli A
J Bone Miner Res; 2006 Apr; 21(4):626-36. PubMed ID: 16598383
[TBL] [Abstract][Full Text] [Related]
9. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
11. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
[TBL] [Abstract][Full Text] [Related]
12. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
[TBL] [Abstract][Full Text] [Related]
13. BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta/activin signaling pathway.
Stewart A; Guan H; Yang K
J Cell Physiol; 2010 Jun; 223(3):658-66. PubMed ID: 20143330
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
15. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.
Boland GM; Perkins G; Hall DJ; Tuan RS
J Cell Biochem; 2004 Dec; 93(6):1210-30. PubMed ID: 15486964
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
[TBL] [Abstract][Full Text] [Related]
17. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing.
Fu X; Han B; Cai S; Lei Y; Sun T; Sheng Z
Wound Repair Regen; 2009; 17(2):185-91. PubMed ID: 19320886
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro.
Liu SB; Hu PZ; Hou Y; Li P; Cao W; Tian Q
Chin Med J (Engl); 2009 Apr; 122(7):839-43. PubMed ID: 19493400
[TBL] [Abstract][Full Text] [Related]
20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
